Rnova Biologicals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 30-07-2024
- Paid Up Capital ₹ 2.00 M
as on 30-07-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.94 M
as on 30-07-2024
- Revenue 6.60%
(FY 2023)
- Profit -45.56%
(FY 2023)
- Ebitda -8.49%
(FY 2023)
- Net Worth 68.24%
(FY 2023)
- Total Assets -6.88%
(FY 2023)
About Rnova Biologicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.49 Cr.
Nagasurendra Lavu and Pattabhi Chundru serve as directors at the Company.
- CIN/LLPIN
U51909AP2016PTC103682
- Company No.
103682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Rajamahendravaram, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rnova Biologicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pattabhi Chundru  | Managing Director | 18-Jul-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagasurendra Lavu | Director | 18-Jul-2016 | Current |
Financial Performance and Corporate Structure Insights of Rnova Biologicals.
Rnova Biologicals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.6% increase. The company also saw a substantial fall in profitability, with a 45.56% decrease in profit. The company's net worth Soared by an impressive increase of 68.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rnova Biologicals?
In 2023, Rnova Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Apr 2024 | ₹1.41 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Oct 2020 | ₹0.86 M | Open |
How Many Employees Work at Rnova Biologicals?
Rnova Biologicals has a workforce of 10 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rnova Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rnova Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
